HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mari Okune Selected Research

nuclear matrix protein 2

1/2022Case of anti-nuclear matrix protein 2 antibody-positive juvenile dermatomyositis preceded by linear cutaneous lupus erythematosus on the face.
1/2022Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash.
1/2021Clinically amyopathic dermatomyositis associated with anti-nuclear matrix protein 2 antibody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mari Okune Research Topics

Disease

2Cutaneous Lupus Erythematosus
05/2022 - 01/2022
2Myositis (Idiopathic Inflammatory Myopathies)
04/2022 - 01/2022
2Dermatomyositis (Dermatopolymyositis)
01/2022 - 01/2022
2Neoplasms (Cancer)
01/2022 - 04/2021
1Asthma (Bronchial Asthma)
05/2022
1Arthralgia (Joint Pain)
05/2022
1Diffuse alopecia
05/2022
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2022
1Atopic Dermatitis (Atopic Eczema)
05/2022
1Calcinosis
01/2022
1Exanthema (Rash)
01/2022
1Bowen's Disease (Disease, Bowen)
04/2021
1Ulcer
04/2021
1Diabetes Mellitus
04/2021
1Actinic Keratosis
04/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2021
1Amyopathic dermatomyositis
01/2021
1Dermatitis
04/2017
1Primary Myelofibrosis (Myelosclerosis)
01/2017
1Melanoma (Melanoma, Malignant)
09/2016
1Nervous System Diseases (Neurological Disorders)
09/2016
1Paresthesia (Dysesthesia)
09/2016
1Polyradiculoneuropathy (Polyradiculoneuritis)
09/2016
1Guillain-Barre Syndrome
09/2016
1Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
09/2016

Drug/Important Bio-Agent (IBA)

3nuclear matrix protein 2IBA
01/2022 - 01/2021
2Monoclonal AntibodiesIBA
05/2022 - 09/2016
2AutoantibodiesIBA
04/2022 - 01/2022
2NivolumabIBA
04/2017 - 09/2016
1AntibodiesIBA
05/2022
1Interleukin-13IBA
05/2022
1AntigensIBA
05/2022
1RibonucleoproteinsIBA
05/2022
1dupilumabIBA
05/2022
1DNA (Deoxyribonucleic Acid)IBA
05/2022
1InterleukinsIBA
05/2022
1Proteins (Proteins, Gene)FDA Link
04/2022
1Immunosuppressive Agents (Immunosuppressants)IBA
04/2021
1Biomarkers (Surrogate Marker)IBA
04/2017
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2017
1Interleukin-6 (Interleukin 6)IBA
04/2017
1Janus KinasesIBA
01/2017
1CalreticulinIBA
01/2017
1SteroidsIBA
09/2016
1Intravenous Immunoglobulins (IVIG)FDA Link
09/2016
1Immune Checkpoint InhibitorsIBA
09/2016

Therapy/Procedure

1Ambulatory Surgical Procedures (Outpatient Surgery)
04/2021
1Activities of Daily Living (ADL)
09/2016